<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Medora | Medical Scores</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<script type="module" src="auth-guard.js"></script>

<style>
body{
  margin:0;
  font-family:Segoe UI,Arial;
  background:radial-gradient(circle at top,#1c2541,#020617);
  color:#eaeaea;
}
header{
  padding:22px 40px;
  background:rgba(28,37,65,.95);
}
.wrapper{
  max-width:1000px;
  margin:auto;
  padding:40px;
}
input{
  width:100%;
  padding:16px;
  border-radius:14px;
  border:none;
  background:#020617;
  color:#fff;
  font-size:16px;
  margin-bottom:30px;
}
.score{
  background:linear-gradient(180deg,#1c2541,#16203a);
  padding:18px 22px;
  border-radius:16px;
  margin-bottom:14px;
  cursor:pointer;
  border:1px solid rgba(255,255,255,.05);
  transition:.25s;
}
.score:hover{background:#24355c}
.score h3{margin:0}
.score span{font-size:13px;color:#b0bcd6}

/* MODAL */
.modal{
  position:fixed;
  inset:0;
  display:none;
  background:rgba(0,0,0,.75);
  align-items:center;
  justify-content:center;
  z-index:999;
}
.modal-box{
  background:#0f172a;
  max-width:900px;
  width:90%;
  max-height:85vh;
  overflow-y:auto;
  padding:30px;
  border-radius:18px;
}
.modal-box h2{margin-top:0}
.modal-box h4{color:#93c5fd;margin-bottom:6px}
.modal-box p,
.modal-box li{color:#e5e7eb;line-height:1.7}
.close{
  margin-top:24px;
  padding:10px 18px;
  border:none;
  border-radius:10px;
  background:#3a86ff;
  color:#fff;
  cursor:pointer;
}
</style>
</head>

<body>

<header>
  <h2>üß† Medical Scores Library</h2>
</header>

<div class="wrapper">
  <input id="search" placeholder="Search medical score...">
  <div id="list"></div>
</div>

<div class="modal" id="modal" onclick="closeModal(event)">
  <div class="modal-box" onclick="event.stopPropagation()">
    <div id="content"></div>
    <button class="close" onclick="closeModal()">Close</button>
  </div>
</div>

<script>
/* =========================
   SCORES DATA ‚Äì PART 1 (1‚Äì10)
   DO NOT CLOSE ARRAY
========================= */

const scores = [

{
name:"APGAR Score",
html:`
<h4>Definition</h4>
<p>The APGAR score is a rapid clinical assessment tool used to evaluate the physiological adaptation of a newborn immediately after birth.</p>

<h4>Historical Background</h4>
<p>Developed in 1952 by Dr. Virginia Apgar to standardize neonatal assessment.</p>

<h4>Components</h4>
<ul>
<li>Appearance (Color)</li>
<li>Pulse (Heart rate)</li>
<li>Grimace (Reflex irritability)</li>
<li>Activity (Muscle tone)</li>
<li>Respiration</li>
</ul>

<h4>Scoring</h4>
<p>Total score ranges from 0 to 10, assessed at 1 and 5 minutes.</p>

<h4>Interpretation</h4>
<ul>
<li>7‚Äì10: Normal adaptation</li>
<li>4‚Äì6: Moderate depression</li>
<li>0‚Äì3: Severe distress ‚Üí immediate resuscitation</li>
</ul>

<h4>Clinical Use</h4>
<p>Guides immediate neonatal resuscitation and outcome comparison.</p>

<h4>Limitations</h4>
<ul>
<li>Not predictive of long-term neurological outcome</li>
<li>Affected by prematurity and maternal medications</li>
</ul>

<h4>Exam Pearl</h4>
<p>A low 5-minute APGAR is more prognostically significant than a low 1-minute score.</p>
`
},

{
name:"Glasgow Coma Scale (GCS)",
html:`
<h4>Definition</h4>
<p>A standardized tool to assess level of consciousness by evaluating eye opening, verbal response, and motor response.</p>

<h4>Components</h4>
<ul>
<li>Eye Opening (E)</li>
<li>Verbal Response (V)</li>
<li>Motor Response (M)</li>
</ul>

<h4>Total Score</h4>
<p>Ranges from 3 to 15.</p>

<h4>Severity Classification</h4>
<ul>
<li>13‚Äì15: Mild brain injury</li>
<li>9‚Äì12: Moderate injury</li>
<li>‚â§8: Severe injury (coma)</li>
</ul>

<h4>Clinical Use</h4>
<p>Trauma assessment, ICU neurological monitoring, coma prognosis.</p>

<h4>Limitations</h4>
<ul>
<li>Intubation interferes with verbal score</li>
<li>Sedatives confound results</li>
</ul>

<h4>Exam Pearl</h4>
<p>GCS ‚â§8 ‚Üí intubate to protect airway.</p>
`
},

{
name:"Bishop Score",
html:`
<h4>Definition</h4>
<p>A scoring system used to predict the success of induction of labor based on cervical readiness.</p>

<h4>Components</h4>
<ul>
<li>Dilation</li>
<li>Effacement</li>
<li>Station</li>
<li>Cervical consistency</li>
<li>Cervical position</li>
</ul>

<h4>Total Score</h4>
<p>0‚Äì13</p>

<h4>Interpretation</h4>
<ul>
<li>‚â§5: Unfavorable cervix</li>
<li>‚â•8: High likelihood of successful induction</li>
</ul>

<h4>Clinical Use</h4>
<p>Guides decision to use prostaglandins versus oxytocin.</p>

<h4>Limitations</h4>
<p>Subjective examiner variability.</p>

<h4>Exam Pearl</h4>
<p>Low Bishop score ‚Üí cervical ripening required.</p>
`
},

{
name:"Wells Score ‚Äì Deep Vein Thrombosis",
html:`
<h4>Purpose</h4>
<p>Estimates pre-test probability of deep vein thrombosis.</p>

<h4>Interpretation</h4>
<ul>
<li>‚â§0: Low probability</li>
<li>1‚Äì2: Moderate probability</li>
<li>‚â•3: High probability</li>
</ul>

<h4>Clinical Algorithm</h4>
<p>Low risk ‚Üí D-dimer. High risk ‚Üí compression ultrasound.</p>

<h4>Limitations</h4>
<p>Subjective elements; not diagnostic alone.</p>
`
},

{
name:"Wells Score ‚Äì Pulmonary Embolism",
html:`
<h4>Purpose</h4>
<p>Estimates probability of pulmonary embolism.</p>

<h4>Interpretation</h4>
<ul>
<li>‚â§4: PE unlikely</li>
<li>>4: PE likely</li>
</ul>

<h4>Clinical Use</h4>
<p>Determines need for CT pulmonary angiography.</p>
`
},

{
name:"CHA‚ÇÇDS‚ÇÇ-VASc Score",
html:`
<h4>Purpose</h4>
<p>Estimates stroke risk in atrial fibrillation.</p>

<h4>Interpretation</h4>
<ul>
<li>0: No anticoagulation</li>
<li>1: Consider anticoagulation</li>
<li>‚â•2: Anticoagulation indicated</li>
</ul>

<h4>Exam Pearl</h4>
<p>Replaced CHADS‚ÇÇ due to better sensitivity.</p>
`
},

{
name:"HAS-BLED Score",
html:`
<h4>Purpose</h4>
<p>Assesses bleeding risk in AF patients on anticoagulation.</p>

<h4>Interpretation</h4>
<p>Score ‚â•3 indicates high bleeding risk (not a contraindication).</p>
`
},

{
name:"CURB-65 Score",
html:`
<h4>Purpose</h4>
<p>Severity assessment in community-acquired pneumonia.</p>

<h4>Management</h4>
<ul>
<li>0‚Äì1: Outpatient</li>
<li>2: Hospital admission</li>
<li>‚â•3: ICU consideration</li>
</ul>
`
},

{
name:"SOFA Score",
html:`
<h4>Purpose</h4>
<p>Quantifies organ failure severity, especially in sepsis.</p>

<h4>Key Concept</h4>
<p>An increase ‚â•2 points indicates organ dysfunction.</p>
`
},

{
name:"qSOFA",
html:`
<h4>Criteria</h4>
<ul>
<li>Respiratory rate ‚â•22</li>
<li>Systolic BP ‚â§100 mmHg</li>
<li>Altered mental status</li>
</ul>

<h4>Interpretation</h4>
<p>Score ‚â•2 ‚Üí high mortality risk.</p>
`
}

/* DO NOT CLOSE ARRAY ‚Äì PART 2 WILL CONTINUE HERE */
,
{
name:"APACHE II Score",
html:`
<h4>Definition</h4>
<p>A severity-of-disease classification system used to estimate hospital mortality in ICU patients.</p>

<h4>Components</h4>
<ul>
<li>Acute Physiology Score (12 variables)</li>
<li>Age points</li>
<li>Chronic health points</li>
</ul>

<h4>Total Score</h4>
<p>0‚Äì71 (higher score = higher mortality)</p>

<h4>Clinical Use</h4>
<p>Prognosis, ICU outcome comparison, research stratification.</p>

<h4>Limitations</h4>
<ul>
<li>Calculated only in first 24 hours</li>
<li>Not for individual treatment decisions</li>
</ul>

<h4>Exam Pearl</h4>
<p>APACHE II is prognostic, not diagnostic.</p>
`
},

{
name:"NIH Stroke Scale (NIHSS)",
html:`
<h4>Definition</h4>
<p>A standardized neurological examination to quantify stroke severity.</p>

<h4>Score Range</h4>
<p>0‚Äì42</p>

<h4>Severity</h4>
<ul>
<li>0: No stroke</li>
<li>1‚Äì4: Minor</li>
<li>5‚Äì15: Moderate</li>
<li>16‚Äì20: Moderate‚Äìsevere</li>
<li>>20: Severe</li>
</ul>

<h4>Clinical Use</h4>
<p>Thrombolysis eligibility, stroke unit monitoring, prognosis.</p>

<h4>Limitations</h4>
<p>Underestimates posterior circulation strokes.</p>

<h4>Exam Pearl</h4>
<p>NIHSS >25 increases hemorrhagic transformation risk after tPA.</p>
`
},

{
name:"TIMI Risk Score (ACS)",
html:`
<h4>Definition</h4>
<p>Risk stratification tool for unstable angina and NSTEMI.</p>

<h4>Score Range</h4>
<p>0‚Äì7</p>

<h4>Clinical Use</h4>
<p>Predicts risk of death, myocardial infarction, and urgent revascularization.</p>

<h4>Limitations</h4>
<ul>
<li>Binary variables</li>
<li>Less accurate than GRACE score</li>
</ul>
`
},

{
name:"GRACE Score",
html:`
<h4>Definition</h4>
<p>Predicts in-hospital and 6-month mortality in acute coronary syndromes.</p>

<h4>Variables</h4>
<ul>
<li>Age</li>
<li>Heart rate</li>
<li>Systolic blood pressure</li>
<li>Serum creatinine</li>
<li>Killip class</li>
<li>Cardiac arrest</li>
<li>ST deviation</li>
<li>Elevated troponin</li>
</ul>

<h4>Clinical Use</h4>
<p>ESC guideline‚Äìrecommended for ACS risk stratification.</p>

<h4>Exam Pearl</h4>
<p>GRACE score >140 ‚Üí early invasive strategy.</p>
`
},

{
name:"Child‚ÄìPugh Score",
html:`
<h4>Definition</h4>
<p>Assesses severity and prognosis of chronic liver disease, mainly cirrhosis.</p>

<h4>Classes</h4>
<ul>
<li>Class A (5‚Äì6): Well compensated</li>
<li>Class B (7‚Äì9): Significant disease</li>
<li>Class C (10‚Äì15): Decompensated</li>
</ul>

<h4>Clinical Use</h4>
<p>Surgical risk assessment and prognosis.</p>

<h4>Limitations</h4>
<p>Includes subjective variables; less precise than MELD.</p>
`
},

{
name:"MELD Score",
html:`
<h4>Definition</h4>
<p>Model for End-Stage Liver Disease predicting 3-month mortality.</p>

<h4>Variables</h4>
<ul>
<li>Serum bilirubin</li>
<li>INR</li>
<li>Serum creatinine</li>
</ul>

<h4>Clinical Use</h4>
<p>Liver transplant allocation and prognosis.</p>

<h4>Limitations</h4>
<p>Underestimates cholestatic liver disease.</p>

<h4>Exam Pearl</h4>
<p>MELD is for allocation, Child‚ÄìPugh is for classification.</p>
`
},

{
name:"Alvarado Score",
html:`
<h4>Definition</h4>
<p>Clinical score estimating probability of acute appendicitis.</p>

<h4>Score Range</h4>
<p>0‚Äì10</p>

<h4>Interpretation</h4>
<ul>
<li>‚â§4: Appendicitis unlikely</li>
<li>5‚Äì6: Observe</li>
<li>‚â•7: Surgical consultation</li>
</ul>

<h4>Limitations</h4>
<p>Less accurate in women, children, and elderly.</p>
`
},

{
name:"Ranson Criteria",
html:`
<h4>Definition</h4>
<p>Predicts severity and mortality in acute pancreatitis.</p>

<h4>Key Concept</h4>
<p>Criteria assessed at admission and at 48 hours.</p>

<h4>Interpretation</h4>
<p>‚â•3 criteria indicate severe pancreatitis.</p>

<h4>Limitations</h4>
<p>Requires 48 hours; less used today.</p>
`
},

{
name:"BISAP Score",
html:`
<h4>Definition</h4>
<p>Early predictor of mortality in acute pancreatitis.</p>

<h4>Components</h4>
<ul>
<li>BUN >25</li>
<li>Impaired mental status</li>
<li>SIRS</li>
<li>Age >60</li>
<li>Pleural effusion</li>
</ul>

<h4>Advantage</h4>
<p>Simple and early risk stratification.</p>
`
},

{
name:"Glasgow-Blatchford Score",
html:`
<h4>Definition</h4>
<p>Predicts need for intervention in upper gastrointestinal bleeding.</p>

<h4>Clinical Use</h4>
<p>Score 0 allows safe outpatient management.</p>

<h4>Advantage</h4>
<p>No endoscopy required initially.</p>
`
}

,
{
name:"Rockall Score",
html:`
<h4>Definition</h4>
<p>Risk stratification tool to predict mortality and rebleeding in upper GI bleeding.</p>

<h4>Components</h4>
<ul>
<li>Age</li>
<li>Shock (BP, HR)</li>
<li>Comorbidity</li>
<li>Diagnosis (endoscopy)</li>
<li>Stigmata of bleeding</li>
</ul>

<h4>Score Range</h4>
<p>0‚Äì11</p>

<h4>Clinical Use</h4>
<p>Prognosis after upper GI bleeding.</p>

<h4>Exam Pearl</h4>
<p>GBS predicts intervention, Rockall predicts mortality.</p>
`
},

{
name:"Framingham Risk Score",
html:`
<h4>Definition</h4>
<p>Estimates 10-year risk of cardiovascular disease.</p>

<h4>Variables</h4>
<ul>
<li>Age</li>
<li>Sex</li>
<li>Total cholesterol</li>
<li>HDL</li>
<li>Blood pressure</li>
<li>Smoking</li>
<li>Diabetes</li>
</ul>

<h4>Risk Categories</h4>
<ul>
<li><10%: Low</li>
<li>10‚Äì20%: Intermediate</li>
<li>>20%: High</li>
</ul>

<h4>Limitations</h4>
<p>Overestimates risk in non-Western populations.</p>
`
},

{
name:"ASCVD Risk Calculator",
html:`
<h4>Definition</h4>
<p>Predicts 10-year and lifetime risk of atherosclerotic cardiovascular disease.</p>

<h4>Clinical Use</h4>
<p>Guides statin therapy decisions.</p>

<h4>Interpretation</h4>
<p>‚â•7.5% ‚Üí consider statin therapy.</p>

<h4>Limitations</h4>
<p>Less accurate in patients <40 or >79 years.</p>
`
},

{
name:"ABCD¬≤ Score",
html:`
<h4>Definition</h4>
<p>Predicts early stroke risk after transient ischemic attack.</p>

<h4>Score Range</h4>
<p>0‚Äì7</p>

<h4>Interpretation</h4>
<ul>
<li>0‚Äì3: Low risk</li>
<li>4‚Äì5: Moderate risk</li>
<li>6‚Äì7: High risk ‚Üí admission</li>
</ul>

<h4>Limitations</h4>
<p>Does not include imaging.</p>
`
},

{
name:"Barthel Index",
html:`
<h4>Definition</h4>
<p>Measures functional independence in activities of daily living.</p>

<h4>Score Range</h4>
<p>0‚Äì100</p>

<h4>Interpretation</h4>
<ul>
<li>0‚Äì20: Total dependence</li>
<li>21‚Äì60: Severe</li>
<li>61‚Äì90: Moderate</li>
<li>91‚Äì100: Minimal dependence</li>
</ul>

<h4>Clinical Use</h4>
<p>Rehabilitation and stroke recovery assessment.</p>
`
},

{
name:"Karnofsky Performance Status",
html:`
<h4>Definition</h4>
<p>Quantifies functional impairment in cancer patients.</p>

<h4>Scale</h4>
<ul>
<li>100: Normal</li>
<li>70: Cares for self</li>
<li>50: Requires assistance</li>
<li>0: Death</li>
</ul>

<h4>Clinical Use</h4>
<p>Chemotherapy tolerance and prognosis.</p>
`
},

{
name:"ECOG Performance Status",
html:`
<h4>Definition</h4>
<p>Simplified functional assessment used in oncology.</p>

<h4>Scale</h4>
<ul>
<li>0: Fully active</li>
<li>1: Restricted strenuous activity</li>
<li>2: Ambulatory, unable to work</li>
<li>3: Limited self-care</li>
<li>4: Completely disabled</li>
</ul>

<h4>Exam Pearl</h4>
<p>ECOG ‚â•3 ‚Üí poor chemotherapy tolerance.</p>
`
},

{
name:"ASA Physical Status Classification",
html:`
<h4>Definition</h4>
<p>Preoperative assessment of anesthetic risk.</p>

<h4>Classes</h4>
<ul>
<li>I: Healthy</li>
<li>II: Mild systemic disease</li>
<li>III: Severe systemic disease</li>
<li>IV: Severe disease, constant threat to life</li>
<li>V: Moribund</li>
</ul>

<h4>Limitations</h4>
<p>Subjective, does not include operative risk.</p>
`
},

{
name:"CHADS‚ÇÇ Score",
html:`
<h4>Definition</h4>
<p>Older scoring system for stroke risk in atrial fibrillation.</p>

<h4>Score Range</h4>
<p>0‚Äì6</p>

<h4>Status</h4>
<p>Largely replaced by CHA‚ÇÇDS‚ÇÇ-VASc.</p>

<h4>Exam Pearl</h4>
<p>Underestimates risk in low-risk patients.</p>
`
},

{
name:"PESI Score",
html:`
<h4>Definition</h4>
<p>Predicts 30-day mortality in pulmonary embolism.</p>

<h4>Clinical Use</h4>
<p>Determines outpatient vs inpatient management.</p>

<h4>Risk Classes</h4>
<p>Class I‚ÄìII: Low risk, Class III‚ÄìV: High risk.</p>
`
}
,
{
name:"NEWS2 Score",
html:`
<h4>Definition</h4>
<p>National Early Warning Score 2 used to detect early clinical deterioration.</p>

<h4>Parameters</h4>
<ul>
<li>Respiratory rate</li>
<li>Oxygen saturation</li>
<li>Supplemental oxygen</li>
<li>Temperature</li>
<li>Systolic blood pressure</li>
<li>Heart rate</li>
<li>Level of consciousness (AVPU)</li>
</ul>

<h4>Interpretation</h4>
<ul>
<li>0‚Äì4: Low risk</li>
<li>5‚Äì6: Medium risk ‚Üí urgent review</li>
<li>‚â•7: High risk ‚Üí critical care</li>
</ul>

<h4>Exam Pearl</h4>
<p>NEWS2 ‚â•5 requires urgent escalation.</p>
`
},

{
name:"Braden Scale",
html:`
<h4>Definition</h4>
<p>Predicts risk of pressure ulcer development.</p>

<h4>Components</h4>
<ul>
<li>Sensory perception</li>
<li>Moisture</li>
<li>Activity</li>
<li>Mobility</li>
<li>Nutrition</li>
<li>Friction & shear</li>
</ul>

<h4>Score Range</h4>
<p>6‚Äì23</p>

<h4>Interpretation</h4>
<ul>
<li>‚â§9: Very high risk</li>
<li>10‚Äì12: High risk</li>
<li>13‚Äì14: Moderate risk</li>
<li>15‚Äì18: Mild risk</li>
</ul>
`
},

{
name:"Mini-Mental State Examination (MMSE)",
html:`
<h4>Definition</h4>
<p>Screening tool for global cognitive function.</p>

<h4>Domains</h4>
<ul>
<li>Orientation</li>
<li>Registration</li>
<li>Attention & calculation</li>
<li>Recall</li>
<li>Language</li>
<li>Visuospatial ability</li>
</ul>

<h4>Score Range</h4>
<p>0‚Äì30</p>

<h4>Interpretation</h4>
<ul>
<li>‚â•24: Normal</li>
<li>18‚Äì23: Mild impairment</li>
<li><18: Severe impairment</li>
</ul>
`
},

{
name:"PHQ-9",
html:`
<h4>Definition</h4>
<p>Self-administered questionnaire assessing depression severity.</p>

<h4>Score Range</h4>
<p>0‚Äì27</p>

<h4>Severity</h4>
<ul>
<li>0‚Äì4: Minimal</li>
<li>5‚Äì9: Mild</li>
<li>10‚Äì14: Moderate</li>
<li>15‚Äì19: Moderately severe</li>
<li>‚â•20: Severe</li>
</ul>

<h4>Exam Pearl</h4>
<p>Question 9 screens for suicidal ideation.</p>
`
},

{
name:"GAD-7",
html:`
<h4>Definition</h4>
<p>Screening and severity tool for generalized anxiety disorder.</p>

<h4>Score Range</h4>
<p>0‚Äì21</p>

<h4>Interpretation</h4>
<ul>
<li>5: Mild</li>
<li>10: Moderate</li>
<li>15: Severe</li>
</ul>
`
},

{
name:"Beck Depression Inventory (BDI)",
html:`
<h4>Definition</h4>
<p>Self-report inventory assessing depression severity.</p>

<h4>Structure</h4>
<p>21 items, each scored 0‚Äì3.</p>

<h4>Score Range</h4>
<p>0‚Äì63</p>

<h4>Interpretation</h4>
<ul>
<li>0‚Äì13: Minimal</li>
<li>14‚Äì19: Mild</li>
<li>20‚Äì28: Moderate</li>
<li>‚â•29: Severe</li>
</ul>
`
},

{
name:"Ottawa Ankle Rules",
html:`
<h4>Definition</h4>
<p>Clinical decision rule to determine need for ankle or foot X-ray after trauma.</p>

<h4>Clinical Impact</h4>
<p>Reduces unnecessary imaging with high sensitivity.</p>

<h4>Limitation</h4>
<p>Low specificity.</p>
`
},

{
name:"Canadian CT Head Rule",
html:`
<h4>Definition</h4>
<p>Identifies patients with minor head injury requiring CT scan.</p>

<h4>High-Risk Criteria</h4>
<ul>
<li>GCS <15 at 2 hours</li>
<li>Suspected open skull fracture</li>
<li>Signs of basal skull fracture</li>
<li>‚â•2 vomiting episodes</li>
<li>Age ‚â•65</li>
</ul>

<h4>Exam Pearl</h4>
<p>Applies only if GCS 13‚Äì15.</p>
`
},

{
name:"Centor Score (Modified McIsaac)",
html:`
<h4>Definition</h4>
<p>Predicts probability of Group A streptococcal pharyngitis.</p>

<h4>Management</h4>
<ul>
<li>‚â§1: No testing</li>
<li>2‚Äì3: Rapid antigen test</li>
<li>‚â•4: Empiric antibiotics</li>
</ul>
`
},

{
name:"Duke Criteria",
html:`
<h4>Definition</h4>
<p>Diagnostic criteria for infective endocarditis.</p>

<h4>Diagnosis</h4>
<ul>
<li>Definite: 2 major OR 1 major + 3 minor</li>
<li>Possible: 1 major + 1 minor</li>
</ul>

<h4>Clinical Use</h4>
<p>Diagnostic standard and research classification.</p>
`
}
,
{
name:"Modified Rankin Scale (mRS)",
html:`
<h4>Definition</h4>
<p>Global disability scale assessing functional outcome after stroke.</p>

<h4>Scale</h4>
<ul>
<li>0: No symptoms</li>
<li>1: No significant disability</li>
<li>2: Slight disability</li>
<li>3: Moderate disability</li>
<li>4: Moderately severe disability</li>
<li>5: Severe disability</li>
<li>6: Death</li>
</ul>

<h4>Clinical Use</h4>
<p>Stroke outcome measurement and rehabilitation planning.</p>

<h4>Exam Pearl</h4>
<p>mRS ‚â§2 indicates functional independence.</p>
`
},

{
name:"SIRS Criteria",
html:`
<h4>Definition</h4>
<p>Defines systemic inflammatory response.</p>

<h4>Criteria (‚â•2)</h4>
<ul>
<li>Temperature >38¬∞C or <36¬∞C</li>
<li>Heart rate >90 bpm</li>
<li>Respiratory rate >20 or PaCO‚ÇÇ <32 mmHg</li>
<li>WBC >12,000 or <4,000 or >10% bands</li>
</ul>

<h4>Clinical Role</h4>
<p>Older sepsis screening tool.</p>

<h4>Exam Pearl</h4>
<p>SIRS ‚â† infection necessarily.</p>
`
},

{
name:"HScore (HLH)",
html:`
<h4>Definition</h4>
<p>Estimates probability of secondary hemophagocytic lymphohistiocytosis.</p>

<h4>Score Range</h4>
<p>0‚Äì337</p>

<h4>Interpretation</h4>
<p>Score ‚â•169 indicates high probability of HLH.</p>

<h4>Clinical Use</h4>
<p>Unexplained fever and cytopenia evaluation.</p>
`
},

{
name:"PADUA Prediction Score",
html:`
<h4>Definition</h4>
<p>Assesses risk of venous thromboembolism in hospitalized medical patients.</p>

<h4>Interpretation</h4>
<p>Score ‚â•4 indicates high VTE risk requiring prophylaxis.</p>

<h4>Clinical Use</h4>
<p>Internal medicine wards.</p>
`
},

{
name:"Caprini Score",
html:`
<h4>Definition</h4>
<p>Risk assessment model for VTE in surgical patients.</p>

<h4>Risk Categories</h4>
<ul>
<li>0‚Äì1: Low</li>
<li>2: Moderate</li>
<li>3‚Äì4: High</li>
<li>‚â•5: Highest risk</li>
</ul>

<h4>Clinical Use</h4>
<p>Pre-operative thromboprophylaxis planning.</p>
`
},

{
name:"MUST Score",
html:`
<h4>Definition</h4>
<p>Malnutrition Universal Screening Tool.</p>

<h4>Score</h4>
<ul>
<li>0: Low risk</li>
<li>1: Medium risk</li>
<li>‚â•2: High risk</li>
</ul>

<h4>Clinical Use</h4>
<p>Hospital and community nutrition screening.</p>
`
},

{
name:"FIB-4 Index",
html:`
<h4>Definition</h4>
<p>Non-invasive marker of liver fibrosis.</p>

<h4>Interpretation</h4>
<ul>
<li><1.3: Low fibrosis</li>
<li>‚â•2.67: Advanced fibrosis likely</li>
</ul>

<h4>Clinical Use</h4>
<p>Chronic hepatitis and NAFLD assessment.</p>
`
},

{
name:"SAPS II",
html:`
<h4>Definition</h4>
<p>Simplified Acute Physiology Score II predicting hospital mortality in ICU.</p>

<h4>Clinical Use</h4>
<p>Research and outcome benchmarking.</p>

<h4>Limitation</h4>
<p>Population-based, not for individual decisions.</p>
`
},

{
name:"Shock Index",
html:`
<h4>Definition</h4>
<p>Heart Rate / Systolic Blood Pressure.</p>

<h4>Interpretation</h4>
<ul>
<li>0.5‚Äì0.7: Normal</li>
<li>‚â•1: Severe shock</li>
</ul>

<h4>Clinical Use</h4>
<p>Trauma and sepsis triage.</p>
`
},

{
name:"FOUR Score",
html:`
<h4>Definition</h4>
<p>Neurological coma scale replacing GCS in intubated patients.</p>

<h4>Score Range</h4>
<p>0‚Äì16</p>

<h4>Advantages</h4>
<ul>
<li>No verbal component</li>
<li>Better ICU prognostication</li>
</ul>

<h4>Exam Pearl</h4>
<p>FOUR score is superior to GCS in intubated patients.</p>
`
}
,
{
name:"Hunt‚ÄìHess Scale",
html:`
<h4>Definition</h4>
<p>Clinical grading system used to assess severity of subarachnoid hemorrhage.</p>

<h4>Grades</h4>
<ul>
<li>I: Asymptomatic or mild headache</li>
<li>II: Moderate headache, nuchal rigidity</li>
<li>III: Drowsiness, confusion</li>
<li>IV: Stupor, severe deficit</li>
<li>V: Coma</li>
</ul>

<h4>Clinical Use</h4>
<p>Prognosis estimation and ICU triage.</p>

<h4>Exam Pearl</h4>
<p>Higher grade ‚Üí higher mortality and vasospasm risk.</p>
`
},

{
name:"Fisher Scale",
html:`
<h4>Definition</h4>
<p>CT-based grading system predicting risk of cerebral vasospasm after SAH.</p>

<h4>Grades</h4>
<ul>
<li>I: No blood</li>
<li>II: Thin diffuse blood</li>
<li>III: Thick clot (>1 mm)</li>
<li>IV: Intraventricular or intracerebral hemorrhage</li>
</ul>

<h4>Limitation</h4>
<p>Does not assess clinical status.</p>
`
},

{
name:"Wells‚ÄìRiley Score",
html:`
<h4>Definition</h4>
<p>Epidemiological model estimating risk of airborne tuberculosis transmission.</p>

<h4>Clinical Use</h4>
<p>Public health, infection control, hospital isolation planning.</p>

<h4>Limitation</h4>
<p>Model-based assumptions; not for individual diagnosis.</p>
`
},

{
name:"Maddrey‚Äôs Discriminant Function",
html:`
<h4>Definition</h4>
<p>Predicts mortality in alcoholic hepatitis and guides steroid therapy.</p>

<h4>Formula</h4>
<p>DF = 4.6 √ó (PT prolongation) + serum bilirubin</p>

<h4>Interpretation</h4>
<p>DF ‚â•32 indicates severe disease.</p>

<h4>Clinical Use</h4>
<p>Hepatology and ICU decision-making.</p>
`
},

{
name:"Lille Score",
html:`
<h4>Definition</h4>
<p>Evaluates response to corticosteroids in severe alcoholic hepatitis.</p>

<h4>Interpretation</h4>
<p>Score >0.45 ‚Üí non-responder ‚Üí stop steroids.</p>

<h4>Advantage</h4>
<p>Dynamic response-based assessment.</p>
`
},

{
name:"CRB-65 Score",
html:`
<h4>Definition</h4>
<p>Simplified pneumonia severity score without urea measurement.</p>

<h4>Components</h4>
<ul>
<li>Confusion</li>
<li>Respiratory rate ‚â•30</li>
<li>Blood pressure <90/60</li>
<li>Age ‚â•65</li>
</ul>

<h4>Interpretation</h4>
<p>Score ‚â•2 ‚Üí hospital admission.</p>
`
},

{
name:"Child‚ÄìTurcotte Score",
html:`
<h4>Definition</h4>
<p>Original predecessor of Child‚ÄìPugh score for liver disease severity.</p>

<h4>Components</h4>
<ul>
<li>Ascites</li>
<li>Encephalopathy</li>
<li>Nutritional status</li>
<li>Albumin</li>
<li>Bilirubin</li>
</ul>

<h4>Status</h4>
<p>Largely obsolete, replaced by Child‚ÄìPugh.</p>
`
},

{
name:"McCabe Score",
html:`
<h4>Definition</h4>
<p>Classifies severity of underlying disease based on life expectancy.</p>

<h4>Categories</h4>
<ul>
<li>Non-fatal disease</li>
<li>Ultimately fatal disease (‚â§5 years)</li>
<li>Rapidly fatal disease (‚â§1 year)</li>
</ul>

<h4>Clinical Use</h4>
<p>Infection and sepsis prognosis studies.</p>
`
},

{
name:"pSOFA Score",
html:`
<h4>Definition</h4>
<p>Pediatric adaptation of SOFA score for organ dysfunction.</p>

<h4>Systems Assessed</h4>
<ul>
<li>Respiratory</li>
<li>Cardiovascular</li>
<li>Hepatic</li>
<li>Coagulation</li>
<li>Renal</li>
<li>Neurologic</li>
</ul>

<h4>Clinical Use</h4>
<p>Pediatric sepsis diagnosis and prognosis.</p>
`
},

{
name:"LACE Index",
html:`
<h4>Definition</h4>
<p>Predicts 30-day readmission or death after hospital discharge.</p>

<h4>Components</h4>
<ul>
<li>Length of stay</li>
<li>Acuity of admission</li>
<li>Comorbidities</li>
<li>Emergency visits</li>
</ul>

<h4>Interpretation</h4>
<p>Score ‚â•10 indicates high readmission risk.</p>
`
}
,
{
name:"CHA‚ÇÇDS‚ÇÇ Score (Original CHADS)",
html:`
<h4>Definition</h4>
<p>Early clinical prediction rule estimating annual stroke risk in atrial fibrillation.</p>

<h4>Components</h4>
<ul>
<li>Congestive heart failure</li>
<li>Hypertension</li>
<li>Age ‚â•75</li>
<li>Diabetes mellitus</li>
<li>Stroke/TIA (2 points)</li>
</ul>

<h4>Score Range</h4>
<p>0‚Äì6</p>

<h4>Limitations</h4>
<p>Underestimates stroke risk in low-risk patients.</p>

<h4>Exam Pearl</h4>
<p>Foundation for CHA‚ÇÇDS‚ÇÇ-VASc.</p>
`
},

{
name:"AIMS65 Score",
html:`
<h4>Definition</h4>
<p>Predicts in-hospital mortality in upper gastrointestinal bleeding.</p>

<h4>Components</h4>
<ul>
<li>Albumin <3.0 g/dL</li>
<li>INR >1.5</li>
<li>Altered mental status</li>
<li>Systolic BP ‚â§90 mmHg</li>
<li>Age ‚â•65</li>
</ul>

<h4>Interpretation</h4>
<p>Score ‚â•2 ‚Üí increased mortality risk.</p>
`
},

{
name:"CALL Score (COVID-19)",
html:`
<h4>Definition</h4>
<p>Predicts progression to severe COVID-19 pneumonia.</p>

<h4>Components</h4>
<ul>
<li>Comorbidity</li>
<li>Age</li>
<li>Lymphocyte count</li>
<li>LDH level</li>
</ul>

<h4>Clinical Use</h4>
<p>COVID ward triage and resource allocation.</p>
`
},

{
name:"CURB Score (Without Age)",
html:`
<h4>Definition</h4>
<p>Simplified pneumonia severity score excluding age.</p>

<h4>Components</h4>
<ul>
<li>Confusion</li>
<li>Urea >7 mmol/L</li>
<li>Respiratory rate ‚â•30</li>
<li>Blood pressure <90/60</li>
</ul>

<h4>Limitation</h4>
<p>Less validated than CURB-65.</p>
`
},

{
name:"CHA‚ÇÇDS‚ÇÇ-VASc-R Score",
html:`
<h4>Definition</h4>
<p>Modified CHA‚ÇÇDS‚ÇÇ-VASc including renal dysfunction.</p>

<h4>Added Variable</h4>
<p>Renal impairment (eGFR <60).</p>

<h4>Status</h4>
<p>Research-based, not guideline standard.</p>
`
},

{
name:"QUICKI Index",
html:`
<h4>Definition</h4>
<p>Quantitative Insulin Sensitivity Check Index.</p>

<h4>Formula</h4>
<p>1 / [log(fasting insulin) + log(fasting glucose)]</p>

<h4>Clinical Use</h4>
<p>Endocrinology and metabolic research.</p>
`
},

{
name:"NAFLD Fibrosis Score (NFS)",
html:`
<h4>Definition</h4>
<p>Non-invasive score predicting advanced fibrosis in NAFLD.</p>

<h4>Variables</h4>
<ul>
<li>Age</li>
<li>BMI</li>
<li>Diabetes</li>
<li>AST/ALT ratio</li>
<li>Platelet count</li>
<li>Albumin</li>
</ul>

<h4>Clinical Use</h4>
<p>Reduces need for liver biopsy.</p>
`
},

{
name:"BODE Index",
html:`
<h4>Definition</h4>
<p>Predicts mortality in COPD patients.</p>

<h4>Components</h4>
<ul>
<li>BMI</li>
<li>FEV‚ÇÅ</li>
<li>Dyspnea (mMRC)</li>
<li>6-minute walk distance</li>
</ul>

<h4>Interpretation</h4>
<p>Higher score ‚Üí worse prognosis.</p>

<h4>Exam Pearl</h4>
<p>BODE is more prognostic than FEV‚ÇÅ alone.</p>
`
},

{
name:"MELD-XI Score",
html:`
<h4>Definition</h4>
<p>Modified MELD score excluding INR.</p>

<h4>Clinical Use</h4>
<p>Patients on anticoagulation or with unreliable INR.</p>

<h4>Limitation</h4>
<p>Less accurate than MELD-Na.</p>
`
},

{
name:"FOUR Score (Expanded ICU Use)",
html:`
<h4>Note</h4>
<p>FOUR score provides better prognostic value in ICU settings than GCS.</p>

<h4>Key Advantage</h4>
<p>Includes brainstem reflexes and respiratory patterns.</p>
`
}
,
{
name:"Charlson Comorbidity Index (CCI)",
html:`
<h4>Definition</h4>
<p>Weighted index predicting 10-year mortality based on comorbid conditions.</p>

<h4>Components</h4>
<p>19 conditions with assigned weights (1‚Äì6).</p>

<h4>Clinical Use</h4>
<p>Prognostic stratification and research adjustment.</p>

<h4>Exam Pearl</h4>
<p>CCI is prognostic, not a treatment guide.</p>
`
},

{
name:"Killip‚ÄìKimball Classification",
html:`
<h4>Definition</h4>
<p>Clinical classification of heart failure severity in acute myocardial infarction.</p>

<h4>Classes</h4>
<ul>
<li>I: No heart failure</li>
<li>II: S3 gallop, basal crackles</li>
<li>III: Acute pulmonary edema</li>
<li>IV: Cardiogenic shock</li>
</ul>

<h4>Exam Pearl</h4>
<p>Killip IV = highest in-hospital mortality.</p>
`
},

{
name:"Blatchford‚ÄìRockall Combined Score",
html:`
<h4>Definition</h4>
<p>Integrated approach combining GBS (intervention need) and Rockall (mortality).</p>

<h4>Clinical Logic</h4>
<p>GBS ‚Üí triage, Rockall ‚Üí prognosis.</p>

<h4>Limitation</h4>
<p>Requires endoscopy for full accuracy.</p>
`
},

{
name:"MELD-Na Score",
html:`
<h4>Definition</h4>
<p>Updated MELD score including serum sodium.</p>

<h4>Clinical Importance</h4>
<p>Current standard for liver transplant allocation.</p>

<h4>Exam Pearl</h4>
<p>MELD-Na has replaced MELD in most systems.</p>
`
},

{
name:"De Ritis Ratio (AST/ALT)",
html:`
<h4>Definition</h4>
<p>Biochemical ratio assessing liver disease etiology and severity.</p>

<h4>Interpretation</h4>
<ul>
<li><1: Viral hepatitis</li>
<li>‚âà2: Alcoholic liver disease</li>
<li>‚âà1: Advanced fibrosis/cirrhosis</li>
</ul>

<h4>Limitation</h4>
<p>Affected by muscle injury and hemolysis.</p>
`
},

{
name:"EuroSCORE II",
html:`
<h4>Definition</h4>
<p>Predicts operative mortality in cardiac surgery.</p>

<h4>Clinical Use</h4>
<p>Preoperative counseling and outcome benchmarking.</p>

<h4>Exam Pearl</h4>
<p>More accurate than original EuroSCORE.</p>
`
},

{
name:"STOP-BANG Questionnaire",
html:`
<h4>Definition</h4>
<p>Screening tool for obstructive sleep apnea.</p>

<h4>Components</h4>
<ul>
<li>Snoring</li>
<li>Tiredness</li>
<li>Observed apnea</li>
<li>Pressure (hypertension)</li>
<li>BMI</li>
<li>Age</li>
<li>Neck circumference</li>
<li>Gender</li>
</ul>

<h4>Interpretation</h4>
<p>Score ‚â•3 ‚Üí high OSA risk.</p>
`
},

{
name:"SOAR Score",
html:`
<h4>Definition</h4>
<p>Predicts mortality after acute ischemic stroke.</p>

<h4>Clinical Use</h4>
<p>Early prognostic counseling.</p>

<h4>Limitation</h4>
<p>Less commonly used than NIHSS + mRS.</p>
`
},

{
name:"CURB-RS Score",
html:`
<h4>Definition</h4>
<p>Renal-sensitive pneumonia severity score.</p>

<h4>Purpose</h4>
<p>Improves mortality prediction in elderly and CKD patients.</p>

<h4>Status</h4>
<p>Research-based, limited adoption.</p>
`
},

{
name:"AIMS65 ‚Äì ICU Emphasis",
html:`
<h4>Note</h4>
<p>AIMS65 score ‚â•3 suggests ICU-level care consideration.</p>

<h4>Clinical Context</h4>
<p>Used for early risk stratification in UGIB.</p>
`
}

// =======================
// CORE LOGIC (DON'T TOUCH)
// =======================
const list = document.getElementById("list");
const search = document.getElementById("search");
const modal = document.getElementById("modal");
const content = document.getElementById("content");

function render(arr){
  list.innerHTML="";
  arr.forEach(s=>{
    const d=document.createElement("div");
    d.className="score";
    d.innerHTML=`<h3>${s.name}</h3><span>Click to view details</span>`;
    d.onclick=()=>openModal(s);
    list.appendChild(d);
  });
}

function openModal(s){
  content.innerHTML=`<h2>${s.name}</h2>`+s.html;
  modal.style.display="flex";
}

function closeModal(){
  modal.style.display="none";
}

search.addEventListener("input",e=>{
  const q=e.target.value.toLowerCase();
  render(scores.filter(s=>s.name.toLowerCase().includes(q)));
});

render(scores);
</script>

</body>
</html>
